MAP PHARMACEUTICALS, INC. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows, 8 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-03-01: Reporting owner KELLEY BERNARD J; Form 4; Security Stock Otion (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2013-03-01: Reporting owner KELLEY BERNARD J; Form 4; Security Stock Otion (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2013-03-01: Reporting owner KELLEY BERNARD J; Form 4; Security Stock Otion (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2013-03-01: Reporting owner KELLEY BERNARD J; Form 4; Security Stock Otion (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-03-01 | KELLEY BERNARD J Director | 4 | Stock Otion (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,949 0 owned after | $6.39 exercise price | 2013-03-04 | |
| 2013-03-01 | KELLEY BERNARD J Director | 4 | Stock Otion (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,500 0 owned after | $12.19 exercise price | 2013-03-04 | |
| 2013-03-01 | KELLEY BERNARD J Director | 4 | Stock Otion (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,500 0 owned after | $3.18 exercise price | 2013-03-04 | |
| 2013-03-01 | KELLEY BERNARD J Director | 4 | Stock Otion (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,500 0 owned after | $14.77 exercise price | 2013-03-04 | |
| 2013-03-01 | KELLEY BERNARD J Director | 4 | Stock Otion (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,500 0 owned after | $16.47 exercise price | 2013-03-04 | |
| 2013-03-01 | KELLEY BERNARD J Director | 4 | Stock Otion (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $11.69 exercise price | 2013-03-04 | |
| 2013-01-26 | Friedman Charlene A Officer (SVP, Gen Counsel & Sec) | 4 | Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 4,500 owned after | $0.00 | 2013-01-29 | |
| 2013-01-25 | Friedman Charlene A Officer (SVP, Gen Counsel & Sec) | 4 | Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,750 8,250 owned after | $0.00 | 2013-01-29 |